India · Delayed Price · Currency is INR Godavari Drugs Statistics
Total Valuation
Godavari Drugs has a market cap or net worth of INR 639.19 million. The enterprise value is 1.23 billion.
| Market Cap | 639.19M |
| Enterprise Value | 1.23B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Godavari Drugs has 7.53 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 7.53M |
| Shares Outstanding | 7.53M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 58.28% |
| Owned by Institutions (%) | n/a |
| Float | 2.84M |
Valuation Ratios
The trailing PE ratio is 16.87.
| PE Ratio | 16.87 |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 32.50 |
| EV / Sales | 1.17 |
| EV / EBITDA | 10.46 |
| EV / EBIT | 13.36 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.42 |
| Debt / EBITDA | 5.23 |
| Debt / FCF | n/a |
| Interest Coverage | 2.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.77% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 9.92M |
| Profits Per Employee | 357,528 |
| Employee Count | 106 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Godavari Drugs has paid 11.26 million in taxes.
| Income Tax | 11.26M |
| Effective Tax Rate | 22.90% |
Stock Price Statistics
The stock price has decreased by -30.14% in the last 52 weeks. The beta is 0.03, so Godavari Drugs's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | -30.14% |
| 50-Day Moving Average | 83.85 |
| 200-Day Moving Average | 91.94 |
| Relative Strength Index (RSI) | 60.63 |
| Average Volume (20 Days) | 3,634 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Godavari Drugs had revenue of INR 1.05 billion and earned 37.90 million in profits. Earnings per share was 5.03.
| Revenue | 1.05B |
| Gross Profit | 297.93M |
| Operating Income | 92.17M |
| Pretax Income | 49.16M |
| Net Income | 37.90M |
| EBITDA | 117.78M |
| EBIT | 92.17M |
| Earnings Per Share (EPS) | 5.03 |
Balance Sheet
The company has 23.73 million in cash and 616.28 million in debt, giving a net cash position of -592.54 million or -78.69 per share.
| Cash & Cash Equivalents | 23.73M |
| Total Debt | 616.28M |
| Net Cash | -592.54M |
| Net Cash Per Share | -78.69 |
| Equity (Book Value) | 433.46M |
| Book Value Per Share | 57.76 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 28.33%, with operating and profit margins of 8.76% and 3.60%.
| Gross Margin | 28.33% |
| Operating Margin | 8.76% |
| Pretax Margin | 4.67% |
| Profit Margin | 3.60% |
| EBITDA Margin | 11.20% |
| EBIT Margin | 8.76% |
| FCF Margin | n/a |
Dividends & Yields
Godavari Drugs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | -0.00% |
| Earnings Yield | 5.93% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |